ATC codes:
M04AA01
EMLc
Indication
Tumour lysis syndrome
ICD11 code:
5C70
INN
Allopurinol
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Solid:
100 mg
(EMLc)
;
300 mg
(EMLc)
EML status history
First added in 2007
(TRS
950)
Sex
All
Age
Children (1 month - 12 years)
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Allopurinol was included on the complementary list of the first EMLc in 2007. The EMLc Subcommittee considered that allopurinol was necessary for management of children within oncology practice and that it should be included in cytotoxics and adjuvant medicines section of the EMLc for this indication.